Astera Labs, Inc. — Director's Dealing 2024

Dec 6, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Astera Labs, Inc. (ALAB)
CIK: 0001736297
Period of Report: 2024-12-04

Reporting Person: Tate Michael Truett (Chief Financial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-12-04	Common Stock	S	3622	$115.4431	Disposed	1425266	Indirect
2024-12-04	Common Stock	S	1900	$116.6616	Disposed	1423366	Indirect
2024-12-04	Common Stock	S	2840	$117.6837	Disposed	1420526	Indirect
2024-12-04	Common Stock	S	2602	$118.4388	Disposed	1417924	Indirect
2024-12-04	Common Stock	S	4353	$119.6697	Disposed	1413571	Indirect
2024-12-04	Common Stock	S	683	$120.5836	Disposed	1412888	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	286424	Direct

Footnotes

F1: The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 30, 2024.

F2: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $115.0900 to $116.0500, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F3: These shares are owned directly by Michael T Tate and Jeanne Larue Tate as Trustees of the Tate 1997 Living Trust Dated April 24, 1997 (the "Tate Trust"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

F4: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $116.0900 to $117.0000, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F5: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $117.1400 to $118.1100, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F6: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $118.1500 to $119.0000, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F7: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $119.1800 to $120.1400, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F8: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $120.1800 to $121.1400, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.